Tag: Biosciences

Earnings Call Insights: Castle Biosciences (CSTL) Q2 2026 Management View "What a great quarter." (Founder, CEO, President & Director Derek ...

Cell reprogramming — the technique of returning adult cells to a more youthful state using four genetic factors identified in ...

Is COGT a good stock to buy? We came across a bullish thesis on Cogent Biosciences, Inc. on X.com by @seedy19tron. In ...

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...

Remember synthetic biology? It was a technology platform that would allow mankind to play God. Not long after Craig Venter ...

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive about the company’s latest RNS regarding its upcoming ...

Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best emerging technology stocks to invest in. On December 19, JPMorgan raised ...